bupivacaine has been researched along with Crush Syndrome in 1 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Crush Syndrome: Severe systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing. It leads to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurita, S | 1 |
Oda, Y | 1 |
Terai, T | 1 |
Yukioka, H | 1 |
Fujimori, M | 1 |
Asada, A | 1 |
1 other study available for bupivacaine and Crush Syndrome
Article | Year |
---|---|
[Two cases of crush syndrome associated with intractable pain].
Topics: Adult; Analgesia, Epidural; Anesthetics, Local; Bupivacaine; Crush Syndrome; Fasciotomy; Female; Hum | 1997 |